학술논문
Use of gene expression profiling to identify responsive patients treated with carboplatin (Carb), paclitaxel (Pac), and everolimus as first-line treatment for cancer of unknown primary (CUP): NCCTG N0871 (Alliance).
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755